Illumina, Inc. ILMN and Natera, Inc. today announced they have
entered into a three-year agreement whereby Illumina will supply Natera
with the HiSeq® 2500 sequencing system and associated consumables for
performing the non-invasive prenatal test (NIPT) Panorama™.
“We are pleased to be selected again as Natera's next-generation
sequencing system provider, to support the growth of its Panorama™
test,” said Nick Naclerio, Senior Vice President of Corporate and
Venture Development at Illumina. “Illumina's goal is to enable the rapid
growth of NIPT and the broader reproductive health market with
technology, products, and ultimately FDA-approved in vitro diagnostic
systems.”
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in